NDC 65162-039 – Guaifenesin and Dextromethorphan HBr

Guaifenesin 1200 mg/1; Dextromethorphan Hydrobromide 60 mg/1 · Tablet, Extended Release · Oral

Human Otc Drug

Product NDC65162-039

Product details

Brand name
Guaifenesin and Dextromethorphan HBr
Generic name
Guaifenesin and Dextromethorphan HBr
Labeler
Amneal Pharmaceuticals LLC
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA209692
Marketed since
November 1, 2018
Listing expires
December 31, 2026
Pharmacologic class
Expectorant; Sigma-1 Agonist; Uncompetitive N-methyl-D-aspartate Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Guaifenesin and Dextromethorphan HBr →

Package NDC codes (3)

Package NDCDescriptionSince
65162-039-031 BOTTLE in 1 CARTON (65162-039-03) / 30 TABLET, EXTENDED RELEASE in 1 BOTTLENov 1, 2018
65162-039-061 BOTTLE in 1 CARTON (65162-039-06) / 60 TABLET, EXTENDED RELEASE in 1 BOTTLENov 1, 2018
65162-039-172 BLISTER PACK in 1 CARTON (65162-039-17) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACKNov 1, 2018

Other Guaifenesin and Dextromethorphan HBr products